###begin article-title 0
Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 262 270 <span type="species:ncbi:9606">patients</span>
Rheumatoid arthritis (RA, MIM 180300) is a common and complex inflammatory disorder. The North American Rheumatoid Arthritis Consortium (NARAC) data, as part of the Genetic Analysis Workshop 15 data, consists of both genome scan and candidate gene studies on RA patients.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4</italic>
###xml 664 670 664 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 672 677 672 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PADI4</italic>
###xml 679 683 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DLG5</italic>
###xml 685 692 685 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
###xml 694 699 694 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4</italic>
###xml 705 711 705 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15</italic>
We applied the backward genotype-trait association (BGTA) algorithm to capture marginal and gene x gene interaction effects of multiple susceptibility loci on RA disease status. A two-stage screening approach was used for the genome scan, whereas a comprehensive study of all possible subsets was conducted for the candidate genes. For the genome scan, we constructed an association network among 39 genetic loci that demonstrated strong signals, 19 of which have been reported in the RA literature. For the candidate genes, we found strong signals for PTPN22 and SUMO4. Based on significant association evidence, we built an association network among the loci of PTPN22, PADI4, DLG5, SLC22A4, SUMO4, and CARD15. To control for false positives, we used permutation tests to constrain the family-wise type I error rate to 1%.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Using the BGTA algorithm, we identified genetic loci and candidate genes that were associated with RA susceptibility and association networks among them. For the first time, we report possible interactions between single-nucleotide polymorphisms/genes, which may be useful for biological interpretation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4</italic>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 510 516 510 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 518 523 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4</italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PADI4</italic>
Rheumatoid arthritis (RA) is a heterogeneous disease with a complex genetic component. Previous studies identified multiple genetic regions that might be associated with RA. Amos et al. [1] identified strong linkage evidence on the major histocompatibility complex (MHC) region, 2q33 (CTLA4) and 11p12 in a genome scan. Plenge et al. [2] selected 14 genes that may be associated with RA or related autoimmune disorders and carried out a case-control study on these candidate genes, with significant results on PTPN22, CTLA4, and PADI4.
###end p 9
###begin p 10
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 871 872 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 959 960 959 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1018 1019 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 622 627 <span type="species:ncbi:9606">human</span>
A common approach used in most association studies is to search, in a marker-by-marker fashion, for loci in association with the disease. This approach precludes consideration of interactions between genetic loci, resulting in loss of information that is important in understanding complex traits. On the other hand, consideration of high-dimensional interactions makes the computational complexity unrealistically high for large-scale studies. To address these difficulties, Lo and Zheng [3,4] showed the backward haplotype transmission association (BHTA) method for case-parent trios to be powerful for studying complex human disorders because it efficiently uses multilocus information. The method was extended in the backward genotype-trait association (BGTA) algorithm for case-control designs by evaluating association information on unphased multilocus genotypes [5]. In this paper, we applied BGTA to the Illumina genome scan (studied by Amos et al. [1]) and the candidate gene data (studied by Plenge et al. [2]) provided by NARAC as part of Problem 2 of Genetic Analysis Workshop 15.
###end p 10
###begin title 11
Methods
###end title 11
###begin title 12
Data processing
###end title 12
###begin p 13
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 328 330 328 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PADI4</italic>
###xml 973 974 973 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 219 225 <span type="species:ncbi:9606">people</span>
The Illumina data consist of 5407 single-nucleotide polymorphisms (SNPs) genotyped from 642 Caucasian families containing 1371 affected siblings with RA [1]. To apply the BGTA method, we first designated all unaffected people as our control group (n = 349). For families that did not contribute a control, we selected one case (n = 474). The level of missing values for the SNPs was <5%. The candidate gene data consist of 839 cases and 855 unrelated controls [2,6]. Genotypes on 20 SNPs in 14 candidate genes were included (Table 1). In Plenge et al. [2], the candidate gene data were checked for errors (~0.5%) and were found to be in Hardy-Weinberg equilibrium. There were 17 SNPs with less than 3% missing data. rs2240340 (PADI4) had ~65% missing (higher in the controls), which could potentially affect the results, and rs1061622 and 5509_5511delCAA had ~15% missing (also higher in the controls). For both data sets, we imputed the missing genotypes using fastPhase [6].
###end p 13
###begin p 14
20 SNPs genotyped on the loci of 14 putative RA candidate genes
###end p 14
###begin title 15
BGTA screening
###end title 15
###begin p 16
###xml 6 8 6 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 32 34 32 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
Given k SNP markers, there are 3k possible unphased genotypes. The association information score - the genotype-trait distortion (GTD) statistic - used by BGTA is defined on the sum of the squared difference between individual genotype's sample relative frequency among the cases and the controls, i.e.,
###end p 16
###begin p 17

###end p 17
###begin p 18
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 7 9 7 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></sub>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 14 16 14 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">u </italic>
###xml 14 16 14 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>u </italic></sub>
###xml 90 92 90 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i </italic>
###xml 100 102 100 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 185 187 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 185 187 185 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></sub>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">u</italic>
###xml 192 193 192 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>u</italic></sub>
###xml 194 196 194 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-2</sup>
###xml 473 475 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 562 564 558 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 583 584 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 624 625 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 735 737 731 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 875 877 871 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 906 908 902 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 1050 1051 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
where nd and nu are total numbers of cases and controls, and  and  are counts of genotype i (on the k markers under study) among cases and controls, respectively. With the constant (1/nd + 1/nu)-2, GTD has expectation 1 asymptotically under the null hypothesis of no association. If a marker is removed from the studied set, the GTD score might decrease or increase, thereby reflecting the contribution of that marker. The genotype-trait association (GTA) score for marker M given a current set of markers is defined as , where DeltaGTD is the GTD score without M minus the GTD with M, and  is an adjusting term defined in [5] that makes GTA have expectation 0 when none of the markers in the subset is associated with the trait. When M is not associated with the disease but some of the selected markers are, GTA is positive, indicating an information gain that occurs when M (i.e., noise) is removed. If M is associated with the trait, GTA will be negative, indicating an information loss, and the magnitude of its value reflects the importance of M.
###end p 18
###begin p 19
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 287 304 287 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BGTA-irreducible </italic>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Based on GTA, BGTA is a backward greedy search algorithm that removes markers that lead to information gain until no further gain is possible (see the flowchart in Figure 1). BGTA screening returns a small "optimal" cluster of markers with the peak GTD score. Herein, a subset is deemed BGTA-irreducible if no marker can be removed without lowering the GTD score. For a large number of markers, such a backward screening is not informative initially due to sparseness issues in high dimensions. Thus, BGTA has been implemented to screen a large number of random marker subsets [5]. In this paper, GTD scores of retained local optimal clusters are recorded, which measure the information content of each retained local optimal cluster. Local optimal clusters of SNPs with GTD score higher than a selection threshold are selected as important.
###end p 19
###begin p 20
Flowchart for the analysis of the genome scan data.
###end p 20
###begin title 21
Two-stage SNP selection
###end title 21
###begin p 22
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
To overcome the computational complexity of analyzing 5407 SNPs while also considering interactions, we developed a two-stage SNP selection process (see Figure 1 for a flowchart). We assume that SNPs with high-dimensional interaction information will show some signal in pairwise GTD scores (this is an assumption that reduces computational burden). In Stage 1, we selected 1000 BGTA-irreducible pairs of SNPs with top GTD scores, which also included 22 SNPs with top marginal GTDs. This yielded 707 unique SNPs for the second stage, where we performed a regular BGTA screening on 700,000 random subsets of 8 SNPs. For discussion on the size of the subsets and the number of repeats, see Zheng et al. [5].
###end p 22
###begin title 23
Candidate gene study
###end title 23
###begin p 24
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">20 </sup>
For the candidate gene set, we evaluated a total of 220 - 1 GTD scores on all possible subsets of 20 SNPs (except for the empty set) to enumerate GTD's distribution for each subset size. Then we performed 30,000 greedy BGTA screenings on subsets of 8 SNPs to identify local optimal BGTA-irreducible SNP clusters.
###end p 24
###begin title 25
Selection threshold and evaluation of significance
###end title 25
###begin p 26
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
To estimate the distribution of GTD scores of local optimal BGTA-irreducible SNP clusters under the null hypothesis that no SNP is associated with the trait, we permuted the labels of disease status to create a simulated data set. For the two-stage study, we examined the GTD score density of returned clusters in the second stage from complete two-stage analyses of 50 permuted data sets. False discovery rate (FDR) was controlled by comparing the observed real density and the density under the null hypothesis (see [7-9]). For the candidate gene study, we set the selection threshold for each SNP subset size to be the maximum among 100 permuted replicates (the red dotted line in Figure 2) and identified local optimal BGTA-irreducible SNP subsets as significant at the 1% family-wise level. The relatively small number of permutations was due to the high computational burden of the analytical approach. This would result in non-trivial margin of error for the significance levels evaluated, which needs to be taken into consideration when interpreting the results.
###end p 26
###begin p 27
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Evaluation of significance of in the RA candidategene study</bold>
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">20 </sup>
Evaluation of significance of in the RA candidategene study. For subsets of a given size, we plotted the highest GTD score (red solid line) with a 95% confidence interval (with Bonferroni correction for 220 - 1 multiple comparisons). The top GTD scores for sets of two to eight marker sets were significantly higher than the expected value under the null hypothesis (black dotted line at 1). Based on 100 permuted data sets, at different subset sizes, the black solid line displays the median maximum GTD scores and the vertical bars are the 95% confidence interval of permutations. For each permutation, we also calculated Bonferroni-corrected 95% confidence intervals for the maximum GTD scores. The blue shading indicates the coverage of these 100 confidence intervals at each subset size (the darkest being 0.9 to 1 (or 90 to 100%) and the lightest being 0.0 to 0.1 (or 0 to 10%)).
###end p 27
###begin title 28
Association network construction
###end title 28
###begin p 29
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
For subsets identified with more than one SNP, we constructed a graphical network using the graph exploration system GUESS [10] (Figures 3 and 4). A direct edge indicates a two-SNP cluster. For clusters with more than two SNPs, a non-SNP node was created with all involved SNP connected to it.
###end p 29
###begin p 30
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genome-wide association network for rheumatoid arthritis</bold>
Genome-wide association network for rheumatoid arthritis. A different color represents each chromosome.
###end p 30
###begin p 31
Association network of candidate gene loci with significant signals.
###end p 31
###begin title 32
Results and discussion
###end title 32
###begin title 33
Genome scan results
###end title 33
###begin p 34
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 768 773 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PADI4</italic>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4</italic>
###xml 1091 1092 1091 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1113 1114 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1221 1227 1221 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
From the two-stage screening of the Illumina data, clusters of SNPs with high GTD scores were returned as important. Based on 50 permutations, we estimated the FDR as described by Storey and Tibshirani [7] at different GTD levels. Due to the small number of permutations, the estimated FDR has a high level of uncertainty for small FDR values. Therefore, we set the selection threshold of GTD to control for FDR at 30% for the association network construction while indicating in Table 2 SNPs with stronger signals at FDR = 15%. Using the individual clusters, we built an association network (Figure 3) based on the joint return clusters of those loci. One central and four satellite subnetworks are notable, and a number of loci seem to serve as hubs (e.g., 1p36.22 (PADI4), 2q33.3 (CTLA4), 5p15.33, 8q24.23, 14q11.2, 14q12, and 18p11.21), which have a large number of interaction edges with other loci. The literature suggests that seven out of these eight loci have previously been found to be associated with susceptibility to RA. All 39 marker loci in the association network of Figure 3 are listed in Table 2, about half of which were previously reported in the RA literature. One important RA susceptibility gene, PTPN22, was not among these 39 loci, but its signal was right below our selection threshold.
###end p 34
###begin p 35
Loci with a high joint GTD score identified in the genome scan
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aMultiple SNPs in LD were found in significant clusters.
###end p 36
###begin p 37
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
bThis locus is 10 Mb away from SLC22A4.
###end p 37
###begin title 38
Candidate genes results
###end title 38
###begin p 39
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN2</italic>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4</italic>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
For the candidate gene data, we studied all possible subsets of SNPs and identified eight significant BGTA-irreducible subsets on seven SNPs after controlling for family-wise type I error. The marginally significant (one-marker subset) SNPs are rs2476601 (PTPN22), and rs237025 and rs577001 (both at the locus of SUMO4). The significantly associated subsets with two or more SNPs represent possible interactions between these candidate genes in affecting the risk of developing RA. In Figure 4, red edges indicate interactions involving more than two SNPs, whereas blue edges indicate pairwise interactions between two SNPs. As previously identified in [2], we found PTPN22 and PADI4. However, the SNP at locus PADI4 has a high level of missing values, so results at this locus should be interpreted with caution.
###end p 39
###begin p 40
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 13 14 13 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4</italic>
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 801 807 801 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4 </italic>
###xml 888 896 888 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4 </italic>
###xml 900 907 900 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
Tables 3 and 4 illustrate a three-way interaction among SLC22A4, SUMO4, and CARD15 identified in our results. Table 3 lists the actual genotype distribution on these three SNPs (percentages out of 839 cases and 855 controls that have observed values). Table 4 displays the deviance table from the logistic regression between the disease status and these three SNPs including all possible interactions. Deviance can be directly used as a likelihood-ratio chi-squared test statistic that evaluates the contribution of each additional model term (main effect or interaction) [17]. From the logistic regression, the three-way interaction identified by BGTA is significant even when the main effects and two-way interaction terms were already included in the model. More interestingly, only one SNP at the SUMO4 locus demonstrated a significant main effect, indicating that contributions from SLC22A4 and CARD15 are mostly through interactions.
###end p 40
###begin p 41
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4</italic>
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
Genotype distributions of identified SNPs on SLC22A4, SUMO4, and CARD15 among cases and controlsa
###end p 41
###begin p 42
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15</italic>
aSNPs identified: rs2073838 (SLC22A4), rs577001 (SUMO4), HugotSNP12ms3 (CARD15)
###end p 42
###begin p 43
Logistic regression deviance table and likelihood ratio test results on data shown in Table 3
###end p 43
###begin p 44
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUMO4</italic>
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15</italic>
aSNPs analyzed: rs2073838 (SLC22A4), rs577001 (SUMO4), HugotSNP12ms3 (CARD15)
###end p 44
###begin p 45
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
bBold indicates significant p-values.
###end p 45
###begin p 46
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC22A4 </italic>
Combining the results from the genome scan and the candidate genes results, PTPN22 had the strongest evidence as an RA susceptibility gene. SLC22A4 also showed up in the results of both studies.
###end p 46
###begin title 47
Conclusion
###end title 47
###begin p 48
In this paper, the BGTA approach was applied to identify important genetic loci and gene x gene interactions on susceptibility to RA. Different analytical strategies were tailored for these two data sets of different nature, illustrating the applicability of BGTA and the GTD statistic to different studies. Using the BGTA method, both marginal and gene x gene interaction information were extracted and reflected in the GTD scores. Under a general analytical framework, both analyses result in association networks constructed based on gene clusters with significant association to RA. To overcome the dimensionality problems of a genome scan, we imposed a two-stage scheme based on BGTA screenings. For a small number of candidate genes, we used GTD directly on subsets of genes to identify clusters that were significantly associated with RA disease status. We addressed the multiple comparisons issue using the most direct permutation-based evaluation and controlled the FDR and the family-wise type I error rate. Both association networks identified in this paper demonstrated evidence on gene x gene interaction in affecting the risk of developing RA. Visualization of these networks displays interesting structures that could be used to generate testable biological hypotheses.
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
The author(s) declare that they have no competing interests.
###end p 50
###begin title 51
Acknowledgements
###end title 51
###begin p 52
This research was supported in part by NIH grant R01 GM070789.
###end p 52
###begin p 53
###xml 43 59 43 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMC Proceedings </italic>
This article has been published as part of BMC Proceedings Volume 1 Supplement 1, 2007: Genetic Analysis Workshop 15: Gene Expression Analysis and Approaches to Detecting Multiple Functional Loci. The full contents of the supplement are available online at .
###end p 53
###begin article-title 54
High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33
###end article-title 54
###begin article-title 55
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22</italic>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTLA4</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PADI4</italic>
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4
###end article-title 55
###begin article-title 56
Backward haplotype transmission association (BHTA) algorithm - a fast multiple-marker screening method
###end article-title 56
###begin article-title 57
A demonstration and findings of a statistical approach through reanalysis of inflammatory bowel disease data
###end article-title 57
###begin article-title 58
Backward genotype-trait association (BGTA)-based dissection of complex traits in case-control designs
###end article-title 58
###begin article-title 59
A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase
###end article-title 59
###begin article-title 60
Statistical significance for genomewide studies
###end article-title 60
###begin article-title 61
Large-scale simultaneous hypothesis testing: the choice of a null hypothesis
###end article-title 61
###begin article-title 62
A direct approach to false discovery rates
###end article-title 62
###begin article-title 63
GUESS: a language and interface for graph exploration
###end article-title 63
###begin article-title 64
Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites
###end article-title 64
###begin article-title 65
Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates
###end article-title 65
###begin article-title 66
Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom
###end article-title 66
###begin article-title 67
Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16
###end article-title 67
###begin article-title 68
Localization of a gene for familial recurrent arthritis
###end article-title 68
###begin article-title 69
Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44
###end article-title 69

